Castle Biosciences CSTL Business Segments — Interest Income
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Castle Biosciences in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Castle Biosciences's business segments — interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Castle Biosciences's business segments — interest income?
- Castle Biosciences (CSTL) reported business segments — interest income of $2.55M in Q1 2026.
- How has Castle Biosciences's business segments — interest income changed year-over-year?
- Castle Biosciences's business segments — interest income decreased by 17.9% year-over-year, from $3.1M to $2.55M.
- What is the long-term trend for Castle Biosciences's business segments — interest income?
- Over 3 years (2022 to 2025), Castle Biosciences's business segments — interest income has grown at a 43.7% compound annual growth rate (CAGR), from $3.97M to $11.77M.
- What does business segments — interest income mean?
- Represents the income generated from cash balances, short-term investments, or other interest-bearing assets held by the segment. It provides insight into the segment's ability to generate non-operating returns from its capital base.